JPMorgan raises RXO to neutral from underweight and target price to $30 from $22
RXO•JPMorgan raised its rating on RXO to neutral from underweight and increased its target price to $30 from $22.
Related News
Invesco Ltd: Jefferies raises target price to $32 from $29
IVZ•
Japan bonds pare losses after strong auction, but fiscal worries weigh
TLT•
Accenture contractor removed from FBI following damaging data breach, sources say
ACN•
Spain to France: hold my cerveza
TLT•
Commodities intraday targets and key levels
USO•